Ventas Climbs 1.20% on Healthcare Partnership Ranks 441st in $240M Turnover

Ventas Inc. (VTR) rose 1.20% on Sept. 26, 2025, with a trading volume of $240 million, ranking 441st in the market by turnover. The stock’s performance followed a mix of sector-specific developments and broader market dynamics affecting real estate investment trusts (REITs).

Recent news highlighted a strategic partnership between Ventas and a healthcare services provider, expanding its portfolio of senior housing properties. Analysts noted the deal could enhance recurring revenue streams and diversify tenant exposure, potentially stabilizing cash flows in a high-interest-rate environment. Additionally, a regulatory filing revealed progress in optimizing debt structures, which may reduce leverage ratios and improve credit ratings.

Market participants also pointed to renewed investor confidence in the REIT sector after a Federal Reserve official signaled potential pauses in rate hikes. While Ventas’ yield remains competitive compared to Treasury yields, its valuation metrics, including a forward price-to-earnings ratio of 18.5, suggest moderate growth expectations relative to peers.

Your proposed strategy involves constructing a new 500-stock portfolio daily, ranked by share-turnover, and liquidating positions the next trading day. Current back-testing tools only support single-instrument analyses. To approximate the strategy, testing on a liquid ETF like SPY could provide insights. Alternatively, a custom analysis using raw data and external coding would be required to model the portfolio logic accurately.